OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Racial Disparities in Obesity‐Related Cardiovascular Mortality in the United States: Temporal Trends From 1999 to 2020
Zahra Raisi‐Estabragh, Ofer Kobo, Jennifer H. Mieres, et al.
Journal of the American Heart Association (2023) Vol. 12, Iss. 18
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity
Patricia J. Rodriguez, Brianna M. Goodwin Cartwright, Samuel Gratzl, et al.
JAMA Internal Medicine (2024) Vol. 184, Iss. 9, pp. 1056-1056
Open Access | Times Cited: 49

Addressing the Global Burden of Cardiovascular Disease in Women
Dominique Vervoort, Ruoting Wang, Guowei Li, et al.
Journal of the American College of Cardiology (2024) Vol. 83, Iss. 25, pp. 2690-2707
Closed Access | Times Cited: 15

Wegovy: FDA approves weight loss drug to cut cardiovascular risk
Janice Hopkins Tanne
BMJ (2024), pp. q642-q642
Closed Access | Times Cited: 6

Adipokines in the Crosstalk between Adipose Tissues and Other Organs: Implications in Cardiometabolic Diseases
Shaghayegh Hemat Jouy, Sukrutha Mohan, Giorgia Scichilone, et al.
Biomedicines (2024) Vol. 12, Iss. 9, pp. 2129-2129
Open Access | Times Cited: 5

The Interplay of Genetic Predisposition, Circadian Misalignment, and Metabolic Regulation in Obesity
Sajal Kumar Halder, Girish C. Melkani
Current Obesity Reports (2025) Vol. 14, Iss. 1
Open Access

Cardioprotective effect of genetic ablation of the G-protein coupled receptor kinase GRK2 in adult pancreatic β-cells during high fat diet
Jonathan Snyder, Chunsun Jiang, Ran Hee Choi, et al.
Journal of Biological Chemistry (2025), pp. 108388-108388
Open Access

Advancement of the Implementation of Evidence-based Therapies for Cardiovascular-Kidney-Metabolic Conditions: A Multi-Stakeholder Perspective
Nkiru Osude, Harriette Van Spall, Hayden B. Bosworth, et al.
American Heart Journal (2025)
Closed Access

Temporal trends in cardiovascular mortality among patients with hematological malignancies: a 20-year perspective
Gemina Doolub, Avraham Raichman, Dmitry Abramov, et al.
Expert Review of Cardiovascular Therapy (2025), pp. 1-9
Closed Access

Trends in ischemic heart disease-related mortality in obese population in the United States
Shehroze Tabassum, Faraz Azhar, Fatima Hussain, et al.
Cardiovascular Endocrinology & Metabolism (2025) Vol. 14, Iss. 2
Open Access

Comparative Effectiveness of Semaglutide and Tirzepatide for Weight Loss in Adults with Overweight and Obesity in the US: A Real-World Evidence Study
Patricia J Rodriguez, Brianna M Goodwin Cartwright, Samuel Gratzl, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 9

Cardiac natriuretic peptides
Theodor W. Shalmi, Anne Sophie B Jensen, Jens P. Goetze
Advances in clinical chemistry (2024)
Closed Access | Times Cited: 3

Trends and Disparities in Coronary Artery Disease and Obesity‐Related Mortality in the United States From 1999–2022
Mushood Ahmed, Hira Javaid, Aimen Shafiq, et al.
Endocrinology Diabetes & Metabolism (2024) Vol. 7, Iss. 6
Open Access | Times Cited: 2

Heart failure and cardiomyopathy mortality trends and disparities among obese populations: A 20-year United States study
Yong Hao Yeo, Boon‐Jian San, Ela Ahmad, et al.
Preventive Medicine (2024) Vol. 190, pp. 108179-108179
Closed Access | Times Cited: 2

Healthy overweight and obesity in the young: Prevalence and risk of major adverse cardiovascular events
Paolo Palatini, Francesca Saladini, Lucio Mos, et al.
Nutrition Metabolism and Cardiovascular Diseases (2023) Vol. 34, Iss. 3, pp. 783-791
Open Access | Times Cited: 4

First Year in Review, Second Year in Preview, and the 2023 JAHA Top 10
Bruce Ovbiagele
Journal of the American Heart Association (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1

Classification, Diagnosis, and Treatment of Obesity-Related Heart Diseases
Dan Chen, Juan Feng, HongYan He, et al.
Metabolic Syndrome and Related Disorders (2024) Vol. 22, Iss. 3, pp. 161-169
Closed Access | Times Cited: 1

Cardiometabolic Risk
Abhayjit Singh, Dennis Bruemmer
JACC Advances (2024) Vol. 3, Iss. 4, pp. 100867-100867
Open Access | Times Cited: 1

Managing Obesity in Heart Failure: Latest Evidence and Knowledge Gaps
Ramzi Ibrahim, Hoang Nhat Pham, Amanda R. Vest, et al.
Current Treatment Options in Cardiovascular Medicine (2024) Vol. 26, Iss. 12, pp. 355-367
Open Access | Times Cited: 1

Representation of racialised and ethnically diverse populations in multicentre randomised controlled trials of GLP-1 medicines for obesity: a systematic review and meta-analysis of gaps
Yaanu Jeyakumar, Lisa Richardson, Shohinee Sarma, et al.
BMJ Global Health (2024) Vol. 9, Iss. 11, pp. e017177-e017177
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top